Error loading player: No playable sources found

AM24-SN-11-O

AM24-SN-11-O: Why is My Blood Product Being Quarantined? Investigations that Happen Behind the Scenes (Enduring)

Date
October 23, 2024
Credits
1 General Continuing Education (GEN) | 1 Florida Lab Personnel (FLP) | 1 California Nurse (CN) | 1 California Lab Personnel (CLP) | 1 Physician (PHY)
$30
Standard Price
Members save $5
This product is also available as part of the following products:
Thumbnail for 2024 Annual Meeting On-Demand: FULL ACCESS
By far the best value to watch all the on-demand educational sessions from the 2024 AABB Annual Meeting and earn continuing education credit…

There are various reasons requiring blood products to be isolated from the general inventory, with recipient safety being the top priority. When a blood center notifies a transfusion service to quarantine blood products, the service’s technologists, supervisors, and medical directors typically ask questions such as: Why is our product being quarantined? What is the anticipated timeline for the investigation? Is it advisable to discard the product? In these situations, it is essential that a thorough investigation is conducted to determine the safety and quality of the suspect product. A cross-functional team assesses the products and may include a comprehensive review of donor eligibility and risk assessment. In this session, we will use case-based learning of real-life examples to illustrate common scenarios involving recipient complications and nonconforming raw materials and products. A systematic approach will be presented to address these circumstances and analyze the challenges that may lead to potential delays in resolving these investigations. Blood center recipient complication data and crucial points to consider when submitting a recipient complication will be reviewed. We will describe the role and composition of a blood center’s Material Review Board during the investigation of nonconforming raw materials and products, including detailing options for the final disposition of nonconforming items. Through the session, the audience will be invited to engage in cases and vote on dispositions by utilizing the Audience Response System.

Learning Objectives

  • Examine the various scenarios and contributing factors that may lead to the quarantine of blood products.
  • Review the systematic approach to investigations, including the assessment of donor eligibility and a product’s safety, quality, identity, potency, and purity.
  • Describe the management of possibly nonconforming raw materials and products by a material review board.
  • List options for final disposition of nonconforming raw materials and products.

Moderator

Speaker Image for Shraddha Babariya
American Red Cross

Speakers

Speaker Image for Saqib Alvi
Medical Director, American Red Cross-Baltimore
Speaker Image for Barry Siegfried
American Red Cross

Related Products

Thumbnail for AM24-SN-05-O: Ensuring Blood Availability for Mass Casualty Events (Enduring)
AM24-SN-05-O: Ensuring Blood Availability for Mass Casualty Events (Enduring)
Until recently, there was no coordinated effort to ensure blood would be available in times of mass casualty events…
Thumbnail for AM24-MN-33-O: Resilience Explored: Navigating Post-Pandemic Blood Products Utilization Trends and Supply Challenges in North America (Enduring)
AM24-MN-33-O: Resilience Explored: Navigating Post-Pandemic Blood Products Utilization Trends and Supply Challenges in North America (Enduring)
This educational session presents a comprehensive exploration of post-pandemic blood utilization trends and supply challenges in North America, featuring experts from prominent blood suppliers with a national footprint—the American Red Cross, Canadian Blood Services, and Vitalant…
Thumbnail for AM24-MN-22-O: What is the Status of the U.S. Blood Supply? Preliminary Findings of the 2023 NBCUS and Latest Trends From Blood Collectors (Enduring)
AM24-MN-22-O: What is the Status of the U.S. Blood Supply? Preliminary Findings of the 2023 NBCUS and Latest Trends From Blood Collectors (Enduring)
The biennially conducted National Blood Collection and Utilization Survey (NBCUS) provides the most comprehensive estimation of blood collection and utilization in the United States…
Thumbnail for AM24-MN-12-O: Preventing Blood Product Tracking In a Mass Casualty Event from Becoming a Disaster (Enduring)
AM24-MN-12-O: Preventing Blood Product Tracking In a Mass Casualty Event from Becoming a Disaster (Enduring)
Many hospitals have administrative and clinical elements for Mass Casualty Events (MCE) but often do not include how to determine the number of blood products that will be needed and rarely how the products will be distributed or tracked…